Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants (Q38331225)

2 September 2017

Antagonism of peripheral hepatic cannabinoid receptor-1 improves liver lipid metabolism in mice: evidence from cultured explants (English)

1 reference

2 September 2017

0 references

0 references

0 references

Tony Jourdan

1

0 references

author name string

Laurent Demizieux

2

1 reference

2 September 2017

Joseph Gresti

3

1 reference

2 September 2017

Louiza Djaouti

4

1 reference

2 September 2017

Lila Gaba

5

1 reference

2 September 2017

Bruno Vergès

6

1 reference

2 September 2017

Pascal Degrace

7

1 reference

2 September 2017

language of work or name

English

0 references

publication date

30 January 2012

1 reference

2 September 2017

1 reference

2 September 2017

55

1 reference

2 September 2017

790-799

1 reference

2 September 2017

3

1 reference

Leptin-regulated endocannabinoids are involved in maintaining food intake

2 September 2017

1 reference

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

21 January 2018

1 reference

Drug treatments for obesity: orlistat, sibutramine, and rimonabant.

21 January 2018

1 reference

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

21 January 2018

1 reference

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

21 January 2018

1 reference

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

21 January 2018

1 reference

Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials

21 January 2018

1 reference

CB1 antagonists for obesity--what lessons have we learned from rimonabant?

21 January 2018

1 reference

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice

21 January 2018

1 reference

Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake.

21 January 2018

1 reference

Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats

21 January 2018

1 reference

Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice

21 January 2018

1 reference

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity

21 January 2018

1 reference

Different effects of pioglitazone and rosiglitazone on lipid metabolism in mouse cultured liver explants

21 January 2018

1 reference

Liver carbohydrate and lipid metabolism of insulin-deficient mice is altered by trans-10, cis-12 conjugated linoleic acid.

21 January 2018

1 reference

Conjugated linoleic acid isomers in mitochondria: evidence for an alteration of fatty acid oxidation

21 January 2018

1 reference

Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma

21 January 2018

1 reference

Reduction of hepatic glucose production as a therapeutic target in the treatment of diabetes

21 January 2018

1 reference

Rat glucokinase gene: structure and regulation by insulin

21 January 2018

1 reference

Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes

21 January 2018

1 reference

Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes.

21 January 2018

1 reference

Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes

21 January 2018

1 reference

Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids

21 January 2018

1 reference

Cannabinoid 1 receptor blockade reduces atherosclerosis with enhances reverse cholesterol transport

21 January 2018

1 reference

Malonyl-CoA binding site and the overt carnitine palmitoyltransferase activity reside on the opposite sides of the outer mitochondrial membrane

21 January 2018

1 reference

Regulation of acetyl-CoA carboxylase

21 January 2018

1 reference

Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways

21 January 2018

1 reference

Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance

21 January 2018

1 reference

Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver

21 January 2018

1 reference

Inhibitory effects of SR141716A on G-protein activation in rat brain

21 January 2018

1 reference

The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase

21 January 2018

1 reference

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

21 January 2018

1 reference

7 January 2021

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

7 January 2021

Effect of dietary n-3 and n-6 polyunsaturated fatty acids on lipid-metabolizing enzymes in obese rat liver

1 reference

7 January 2021

Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR-/- apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid

1 reference

7 January 2021

Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth

1 reference

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

7 January 2021

Glucose 6-Phosphate Produced by Glucokinase, but Not Hexokinase I, Promotes the Activation of Hepatic Glycogen Synthase

1 reference

7 January 2021

Evidence for post-transcriptional regulation by insulin of 3-hydroxy-3-methylglutaryl coenzyme A reductase and sterol synthesis in human mononuclear leucocytes

1 reference

7 January 2021

Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation

1 reference

7 January 2021

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24733

1 reference

release_fmgoysa57bcxloyrypkqd7jaui

2 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fmgoysa57bcxloyrypkqd7jaui

24 November 2022

mapped directly with Wikidata item

1 reference